Expertise in
2
conditions

Dr. Alice Y. Ho

Radiation Oncology | Radiology
100 Blossom Street, Cox Building 3, 
Boston, MA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
2
conditions
100 Blossom Street, Cox Building 3, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alice Ho is a Radiation Oncologist and a Radiologist in Boston, Massachusetts. Dr. Ho is highly rated in 2 conditions, according to our data. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Breast Cancer in Men. Dr. Ho is currently accepting new patients.

Her clinical research consists of co-authoring 96 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Radiology
Licenses
Therapeutic Radiology in NY
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

100 Blossom Street, Cox Building 3, Boston, MA 02114
Other Locations
1275 York Ave, New York, NY 10065

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Recruiting
Publish Date: November 13, 2025
Intervention Type: Radiation, Other
Study Phase: Phase 3
P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer
P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug, Radiation
Study Drugs: Pembrolizumab, Paclitaxel, Carboplatin, Cyclophosphamide, Doxorubicin, Capecitabine
Study Phase: Phase 2
A Phase II Study of NirAparib, Dostarlimab and Radiotherapy in Metastatic, PD-L1 Negative or Immunotherapy-Refractory Triple-Negative Breast Cancer (NADiR)
A Phase II Study of NirAparib, Dostarlimab and Radiotherapy in Metastatic, PD-L1 Negative or Immunotherapy-Refractory Triple-Negative Breast Cancer (NADiR)
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2025
Intervention Type: Radiation, Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 2
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients (UNITY)
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients (UNITY)
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Radiation, Drug
Study Drug: Niraparib
Study Phase: Phase 1
Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer
Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Drug, Radiation
Study Drug: pembrolizumab
Study Phase: Phase 1/Phase 2
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: November 01, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
A Multicenter Single Arm Phase II Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients
A Multicenter Single Arm Phase II Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients
Enrollment Status: Completed
Publish Date: October 19, 2022
Intervention Type: Drug, Radiation
Study Drug: Pembrolizumab
Study Phase: Phase 2
Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Patients Requiring Treatment of the Internal Mammary Lymph Nodes
Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Patients Requiring Treatment of the Internal Mammary Lymph Nodes
Enrollment Status: Completed
Publish Date: April 20, 2021
Intervention Type: Radiation, Behavioral
Study Phase: Not Applicable
View 7 Less Clinical Trials

96 Total Publications

Facts and hopes in radioimmunotherapy for localized stages of cancer.
Facts and hopes in radioimmunotherapy for localized stages of cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 30, 2025
Similar Doctors
Expertise in
22
conditions
Dr. Theodore S. Hong
Radiation Oncology
Expertise in
22
conditions
Dr. Theodore S. Hong
Radiation Oncology

Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

330 Brookline Ave, 
Boston, MA 
 (2.5 miles away)
617-754-8612
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Theodore Hong is a Radiation Oncologist in Boston, Massachusetts. Dr. Hong is highly rated in 22 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Hong is currently accepting new patients.

Expertise in
19
conditions
Dr. Brian M. Alexander
Radiation Oncology
Expertise in
19
conditions
Dr. Brian M. Alexander
Radiation Oncology
75 Francis St, 
Boston, MA 
 (2.7 miles away)
617-732-5500
Languages Spoken:
English
See accepted insurances

Brian Alexander is a Radiation Oncologist in Boston, Massachusetts. Dr. Alexander is highly rated in 19 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.

Expertise in
24
conditions
Dr. Helen A. Shih
Radiation Oncology
Expertise in
24
conditions
Dr. Helen A. Shih
Radiation Oncology

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (0.1 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Helen Shih is a Radiation Oncologist in Boston, Massachusetts. Dr. Shih is highly rated in 24 conditions, according to our data. Her top areas of expertise are Meningioma, Brain Tumor, Astrocytoma, Acoustic Neuroma, and Tissue Biopsy. Dr. Shih is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ho's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile